Mount Vernon Associates’s Johnson & Johnson JNJ Stock Holding History

Mount Vernon Associates’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$551K	Sell	2,171 -15	-0.7%	-$3.5K	0.36%	42
2026 Q1	$534K	Buy	2,186 +135	+7%	+$31.4K	0.38%	41
2025 Q4	$425K	Buy	2,051 +57	+3%	+$11.3K	0.29%	42
2025 Q3	$370K	Sell	1,994 -4	-0.2%	-$685	0.26%	41
2025 Q2	$305K	Buy	1,998 +73	+4%	+$11.2K	0.22%	43
2025 Q1	$319K	Sell	1,925 -15	-0.8%	-$2.35K	0.26%	43
2024 Q4	$281K	Hold	1,940	–	–	0.22%	45
2024 Q3	$314K	Sell	1,940 -155	-7%	-$24.7K	0.25%	47
2024 Q2	$306K	Sell	2,095 -281	-12%	-$41.8K	0.27%	46
2024 Q1	$376K	Sell	2,376 -10	-0.4%	-$1.59K	0.32%	44
2023 Q4	$374K	Sell	2,386 -24	-1%	-$3.68K	0.37%	41
2023 Q3	$375K	Hold	2,410	–	–	0.41%	41
2023 Q2	$399K	Hold	2,410	–	–	0.42%	40
2023 Q1	$374K	Hold	2,410	–	–	0.44%	38
2022 Q4	$426K	Sell	2,410 -30	-1%	-$5.18K	0.55%	36
2022 Q3	$399K	Sell	2,440 -10	-0.4%	-$1.69K	0.52%	36
2022 Q2	$435K	Sell	2,450 -20	-0.8%	-$3.56K	0.53%	36
2022 Q1	$438K	Sell	2,470 -35	-1%	-$5.96K	0.42%	38
2021 Q4	$429K	Hold	2,505	–	–	0.37%	39
2021 Q3	$405K	Sell	2,505 -25	-1%	-$4.26K	0.37%	41
2021 Q2	$417K	Hold	2,530	–	–	0.38%	40
2021 Q1	$416K	Sell	2,530 -35	-1%	-$5.66K	0.41%	39
2020 Q4	$404K	Sell	2,565 -15	-0.6%	-$2.21K	0.42%	38
2020 Q3	$384K	Sell	2,580 -35	-1%	-$5.18K	0.46%	36
2020 Q2	$368K	Sell	2,615 -5	-0.2%	-$729	0.48%	34
2020 Q1	$344K	Sell	2,620 -10	-0.4%	-$1.42K	0.58%	31
2019 Q4	$384K	Hold	2,630	–	–	0.52%	36
2019 Q3	$340K	Sell	2,630 -100	-4%	-$13.2K	0.51%	37
2019 Q2	$380K	Hold	2,730	–	–	0.57%	36
2019 Q1	$382K	Hold	2,730	–	–	0.58%	36
2018 Q4	$352K	Sell	2,730 -100	-4%	-$13.9K	0.62%	35
2018 Q3	$391K	Hold	2,830	–	–	0.58%	38
2018 Q2	$343K	Buy	2,830 +150	+6%	+$18.7K	0.53%	39
2018 Q1	$343K	Sell	2,680 -100	-4%	-$13.5K	0.53%	38
2017 Q4	$388K	Sell	2,780 -50	-2%	-$6.96K	0.58%	38
2017 Q3	$368K	Buy	2,830 +1,021	+56%	+$135K	0.61%	37
2017 Q2	$239K	Hold	1,809	–	–	0.43%	46
2017 Q1	$225K	Hold	1,809	–	–	0.41%	49
2016 Q4	$208K	Hold	1,809	–	–	0.41%	50
2016 Q3	$214K	Hold	1,809	–	–	0.44%	49
2016 Q2	$219K	Sell	1,809 -471	-21%	-$53.5K	0.47%	49
2016 Q1	$247K	Hold	2,280	–	–	0.55%	49
2015 Q4	$234K	Hold	2,280	–	–	0.51%	47
2015 Q3	$213K	Sell	2,280 -70	-3%	-$6.77K	0.49%	49
2015 Q2	$229K	Hold	2,350	–	–	0.49%	47
2015 Q1	$236K	Hold	2,350	–	–	0.51%	48
2014 Q4	$246K	Buy	2,350 +160	+7%	+$16.9K	0.56%	51
2014 Q3	$233K	Sell	2,190 -100	-4%	-$10.4K	0.58%	47
2014 Q2	$240K	Sell	2,290 -100	-4%	-$10.1K	0.61%	47
2014 Q1	$235K	Hold	2,390	–	–	0.61%	47
2013 Q4	$219K	Hold	2,390	–	–	0.57%	49
2013 Q3	$207K	Sell	2,390 -150	-6%	-$13.5K	0.63%	46
2013 Q2	$218K	Buy	+2,540	New	+$216K	0.24%	47

Other funds holding JNJ

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Mount Vernon Associates's JNJ Position: Q2 2026 in Review

Mount Vernon Associates reduced its Johnson & Johnson (JNJ) stake by 0.69% in Q2 2026, selling an estimated $3.5K and leaving 2,171 shares worth $551K. The position accounts for 0.36% of the portfolio, ranked #42.

Mount Vernon Associates first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 2,235 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Mount Vernon Associates held 2,171 shares of Johnson & Johnson worth $551K as of Q2 2026.
Mount Vernon Associates sold 15 Johnson & Johnson shares in Q2 2026, an estimated $3.5K.
Johnson & Johnson made up 0.36% of Mount Vernon Associates's portfolio in Q2 2026, its #42 holding.
Mount Vernon Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
2,235 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Mount Vernon Associates's 13F filing for Q2 2026, filed 24 Jul 2026.